Sripal Bangalore, MD, MHA, FSCAI | SCAI

Dr. Bangalore is an interventional cardiologist and a Professor of Medicine with tenure at New York University School of Medicine. He is the Director of invasive and interventional cardiology, Director of Complex Coronary Intervention and Interventional Director, Adult ECMO and MCS Program at Bellevue Hospital; Director of Research for the cardiac catheterization laboratory and the Director for the Cardiovascular Outcomes Group at NYU Langone Medical Center. His clinical expertise is in complex coronary intervention including CTOs, ultra low volume/zero contrast PCI and mechanical circulatory support. His research interests are in comparative effectiveness studies for cardiovascular diseases, particularly stable ischemic heart disease, acute coronary syndromes, hypertension and dyslipidemia. Dr. Bangalore has received grants from the National Institutes of Health, Agency for Healthcare Research and Quality, American Heart Association and from the industry. He has published over 400 articles in leading national and international journals including the NEJM, JAMA, Lancet, Circulation and JACC. His other areas of interest include comparative effectiveness of coronary artery bypass surgery (CABG) vs. percutaneous coronary intervention (PCI), evaluating the efficacy and safety of various stent types in patients undergoing PCI, including patients with diabetes and those in patients with ST segment elevation myocardial infarction and comparative effectiveness of drug eluting stents vs. bare metal stents. He has won a number of awards including the Dr. Gregory Braden Memorial Interventional Cardiology Fellow of the Year Award from the Society for Cardiovascular Angiography and Intervention and the Douglas P. Zipes Distinguished Young Scientist award from the American College of Cardiology.